Search

Search Constraints

You searched for: Author/Creator Strosberg, Jonathan R.

Search Results

3. Clinical Benefits of Above-Standard Dose of Octreotide LAR in Patients With Neuroendocrine Tumors for Control of Carcinoid Syndrome Symptoms: A Multicenter Retrospective Chart Review Study. (5th August 2014)

4. Clinical Benefits of Above‐Standard Dose of Octreotide LAR in Patients With Neuroendocrine Tumors for Control of Carcinoid Syndrome Symptoms: A Multicenter Retrospective Chart Review Study. (5th August 2014)

5. Clinical Outcomes of Patients With Gastrointestinal Malignancies Participating in Phase I Clinical Trials. (February 2018)

9. Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211). Issue 7 (1st March 2023)

10. Recurrence Patterns After Surgical Resection of Gastroenteropancreatic Neuroendocrine Tumors: Analysis From the National Comprehensive Cancer Network Oncology Outcomes Database. Issue 4 (April 2021)